NASD · Healthcare · Diagnostics & Research · USA
Radnet Inc is a mid cap company (market value between $2 billion and $10 billion) in the Diagnostics & Research industry.
RadNet Inc operates a network of diagnostic imaging centers across the United States, providing services including MRI, CT, PET, nuclear medicine, mammography, ultrasound, and X-ray procedures. The company runs imaging centers in multiple states through wholly owned facilities and hospital joint ventures, offering digital health software solutions and teleradiology services through subsidiaries.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the Radnet Inc stock.
Overvalued: intrinsic value $36.30 per share, market price $69.27, margin of safety -90.9% (as of 2026-10-19).
Discounting its cash flows at 10.5% values the shares at $36.30; the price of $69.27 is 91% above that value.
Leak Score: 26/100 on 10 of 12 signals (On Watch).
17 more funds hold it; the full list is part of the paid plan.
All 44 Diagnostics & Research stocks
6 more in this industry show a wider margin of safety.
RDNT is overvalued (as of the 2026-10-19 close). Discounting its cash flows at 10.5% values the shares at $36.30; the price of $69.27 is 91% above that value.
$36.30 per share (as of the 2026-10-19 close), against a market price of $69.27. That is a margin of safety of -90.9%. The value is the average of the valuation methods that apply to this company, recomputed every night after the US close.
26 out of 100, which we rate "On Watch", on 10 of 12 value investing signals.